Contact Us Investor Relations Site Map
 
產品服務單元情境圖
Announcements Home > Investor Relations > Announcements
回列表
TSH Biopharm filed a second-instance appeal against CCPC infringing the patent act and violating the fair trade law, which were all rejected. Date of announcement: 2020/02/18
SEQ_NO.1Time of announcement: 16:26:11Date of events:2020/2/18To which item it meets:paragraph 2
Spokesman:Sun,Yin-NanTitle of spokesman:VicePresidentTelephone no. of spokesman:02-23124200
Statement
 
1.Parties to the legal matter: accuser:TSH Biopharm Corporation Ltd/defendant:the company CCPC 2.Name of the court or disposing agency:Intellectual Property Court 3.Reference/case numbers of relevant documents: Based on the Patent Act of Civil judgment No. 26 of the year 107 . 4.Date of occurrence of the event:2020/02/18 5.Background and circumstances of the matter (including the property/subject matter under dispute):The Company received a letter from the Intellectual Property Court that TSH Biopharm filed a lawsuit against the Company under the Patent Act and Fair Trade Lawsuit. 6.Course and progression of handling of the matter: 1.The company's Kodak film-coated tablets were sued by TSH Biopharm for patent infringement, and the Intellectual Property Court dismissed all the appeals of TSH Biopharm with patent act of civil judgment No.26 of the year107. 2.The company's operation has always complied with the law and discipline, and after trial by the intellectual property court, it did not infringe the patents of others. The Intellectual Property Court has set aside any disorder,and the company deeply respects it. 7.Effect on company finances and business and estimated monetary amount of the effect:none 8.Countermeasures and status of amelioration:none 9.Any other matters that need to be specified:none

 

 
中文版 ENGLISH
 
 
泭第 忒儂泭 泭 忒儂潼泭